Aug 25, 2026 06:59AM
Aug 14, 2026 08:19AM
Jun 1, 2026 07:26AM
Jun 1, 2026 06:55AM
May 29, 2026 03:06PM
May 29, 2026 03:05PM
May 29, 2026 02:54PM Oculis OCS-01 eye drops fail primary endpoints in diabetic macular edema trials
May 7, 2026 05:59AM
May 7, 2026 04:57AM
May 1, 2026 04:00AM
Jan 6, 2026 08:00AM
Dec 19, 2025 07:42AM
Oct 7, 2025 06:39AM
Aug 22, 2025 05:33AM Stifel Reiterates Buy Rating on Oculis Holding AG (OCS)
Apr 15, 2025 03:01PM
Apr 10, 2025 08:04AM
Apr 10, 2025 08:00AM
Apr 1, 2025 04:00AM
Mar 13, 2025 06:41AM
Mar 12, 2025 09:18AM
Jan 7, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Oculis Holding AG (OCS)
Jan 6, 2025 02:12PM
Aug 28, 2024 06:43AM
Aug 27, 2024 04:00AM
Jun 11, 2024 06:42AM
Jun 11, 2024 05:24AM
Jun 10, 2024 05:00AM
Jun 10, 2024 04:30AM Oculis Holding (OCS) Reports Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab
Apr 10, 2024 06:30AM
Dec 20, 2023 06:30AM
Aug 8, 2023 06:30AM
Aug 8, 2023 06:30AM
Apr 26, 2023 07:04AM
Apr 26, 2023 07:00AM
Apr 26, 2023 07:00AM Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs

330,680 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All